189 related articles for article (PubMed ID: 16037308)
21. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Metz TO; Alderson NL; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
[TBL] [Abstract][Full Text] [Related]
22. The Maillard reaction and its consequences for a living body.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
[TBL] [Abstract][Full Text] [Related]
23. Interplay between the maillard reaction and lipid peroxidation in biochemical systems.
Hidalgo FJ; Zamora R
Ann N Y Acad Sci; 2005 Jun; 1043():319-26. PubMed ID: 16037254
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glycosylation processes: the reaction between pyridoxamine and glucose.
Adrover M; Vilanova B; Muñoz F; Donoso J
Chem Biodivers; 2005 Jul; 2(7):964-75. PubMed ID: 17193188
[TBL] [Abstract][Full Text] [Related]
25. Study of degradation pathways of Amadori compounds obtained by glycation of opioid pentapeptide and related smaller fragments: stability, reactions, and spectroscopic properties.
Jakas A; Horvat S
Biopolymers; 2003 Aug; 69(4):421-31. PubMed ID: 12879488
[TBL] [Abstract][Full Text] [Related]
26. Pyridoxal phosphate prevents progression of diabetic nephropathy.
Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
[TBL] [Abstract][Full Text] [Related]
27. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.
Voziyan PA; Metz TO; Baynes JW; Hudson BG
J Biol Chem; 2002 Feb; 277(5):3397-403. PubMed ID: 11729198
[TBL] [Abstract][Full Text] [Related]
28. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.
Williams ME; Bolton WK; Khalifah RG; Degenhardt TP; Schotzinger RJ; McGill JB
Am J Nephrol; 2007; 27(6):605-14. PubMed ID: 17823506
[TBL] [Abstract][Full Text] [Related]
29. Role of pyridoxamine in the formation of the Amadori/Heyns compounds and aggregates during the glycation of beta-lactoglobulin with galactose and tagatose.
Corzo-Martínez M; Moreno FJ; Olano A; Villamiel M
J Agric Food Chem; 2010 Jan; 58(1):500-6. PubMed ID: 20014847
[TBL] [Abstract][Full Text] [Related]
30. Enzymatic transamination of pyridoxamine in tobacco plants.
Huang S; Zhang J; Wu M; Wu Q; Huang L
Plant Sci; 2013 Nov; 212():55-9. PubMed ID: 24094054
[TBL] [Abstract][Full Text] [Related]
31. Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction.
Aldini G; Dalle-Donne I; Colombo R; Maffei Facino R; Milzani A; Carini M
ChemMedChem; 2006 Oct; 1(10):1045-58. PubMed ID: 16915603
[No Abstract] [Full Text] [Related]
32. Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
Swaminathan S; Shah SV
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):143-8. PubMed ID: 18277146
[TBL] [Abstract][Full Text] [Related]
33. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
34. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
[TBL] [Abstract][Full Text] [Related]
35. Pyridoxamine scavenges protein carbonyls and inhibits protein aggregation in oxidative stress-induced human HepG2 hepatocytes.
Dainin K; Ide R; Maeda A; Suyama K; Akagawa M
Biochem Biophys Res Commun; 2017 May; 486(3):845-851. PubMed ID: 28359757
[TBL] [Abstract][Full Text] [Related]
36. Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial.
Van den Eynde MDG; Houben AJHM; Scheijen JLJM; Linkens AMA; Niessen PM; Simons N; Hanssen NMJ; Kusters YHAM; Eussen SJMP; Miyata T; Stehouwer CDA; Schalkwijk CG
Diabetes Obes Metab; 2023 May; 25(5):1280-1291. PubMed ID: 36655410
[TBL] [Abstract][Full Text] [Related]
37. Dicarbonyl intermediates in the maillard reaction.
Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():111-7. PubMed ID: 16037229
[TBL] [Abstract][Full Text] [Related]
38. Preventing cell death induced by carbonyl stress, oxidative stress or mitochondrial toxins with vitamin B anti-AGE agents.
Mehta R; Shangari N; O'Brien PJ
Mol Nutr Food Res; 2008 Mar; 52(3):379-85. PubMed ID: 17918169
[TBL] [Abstract][Full Text] [Related]
39. The Maillard reaction inhibitors and their biological and therapeutic significance.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):156-8. PubMed ID: 15323184
[TBL] [Abstract][Full Text] [Related]
40. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kanková K
Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
